A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer

Consensus molecular subtypes (CMSs) can guide precision treatment of colorectal cancer (CRC). We aim to identify methylation markers to distinguish between CMS2 and CMS3 in patients with CRC, for which an easy test is currently lacking. To this aim, fresh‐frozen tumor tissue of 239 patients with sta...

詳細記述

書誌詳細

出版年:	Molecular Oncology
主要な著者:	Inge van denBerg, Marcel Smid, Robert R. J. Coebergh van den Braak, Mark A. van deWiel, Carolien H. M. vanDeurzen, Vanja deWeerd, John W. M. Martens, Jan N. M. IJzermans, Saskia M. Wilting
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2021-12-01
主題:	colon cancer consensus molecular subtypes marker panel methylation
オンライン･アクセス:	https://doi.org/10.1002/1878-0261.13098